Acknowledgement
This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2016R1D1A3B03934457).
References
- Albrecht J, Sidoryk-Wegrzynowicz M, Zielinska M, Aschner M. Roles of glutamine in neurotransmission. Neuron Glia Biol. 2010. 6: 263-276. https://doi.org/10.1017/S1740925X11000093
- Amores-Sanchez MI, Medina MA. Glutamine, as a precursor of glutathione, and oxidative stress. Mol Genet Metab. 1999. 67: 100-105. https://doi.org/10.1006/mgme.1999.2857
- Ayush O, Jin ZW, Kim HK, Shin Y, Im SY, Lee HK. Glutamine up-regulates MAPK phosphatase-1 induction via activation of Ca2+ → ERK cascade pathway. Biochem Biophys Rep. 2016. 7: 10-19.
- Ayush O, Lee CH, Kim HK, Im SY, Cho BH, Lee HK. Glutamine suppresses dinitrofluorobenzene-induced contact dermatitis by deactivating p38 mitogen-activated protein kinase via induction of MAPK phosphatase-1. J Invest Dermatol. 2013. 133: 723-731. https://doi.org/10.1038/jid.2012.373
- Brondello JM, Pouyssegur J, McKenzie FR. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science. 1999. 286: 2514-2517. https://doi.org/10.1126/science.286.5449.2514
- Chattopadhyay S, Machado-Pinilla R, Manguan-Garcia CManguan-Garcia C et al. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer. Oncogene. 2006. 25: 3335-3345. https://doi.org/10.1038/sj.onc.1209364
- Chi H, Barry SP, Roth RJRoth RJ et al. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA. 2006. 103: 2274-2279. https://doi.org/10.1073/pnas.0510965103
- Deepak P, Sifuentes H, Sherid MD, Stobaugh D, Sadozai Y, Ehrenpreis ED. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study. Am J Gastroenterol. 2013. 108: 99-105. https://doi.org/10.1038/ajg.2012.334
- Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev. 2011. 111: 6130-6185. https://doi.org/10.1021/cr200085w
- Encarnacion S, Calderon J, Gelbard AS, Cooper AJ, Mora J. Glutamine biosynthesis and the utilization of succinate and glutamine by Rhizobium etli and Sinorhizobium meliloti. Microbiology. 1998. 144: 2629-2638. https://doi.org/10.1099/00221287-144-9-2629
- Feldmann M, Maini RN. Perspectives from masters in rheumatology and autoimmunity: can we get closer to a cure for rheumatoid arthritis? Arthritis Rheumatol. 2015. 67: 2283-2291. https://doi.org/10.1002/art.39269
- Feuerherm AJ, Dennis EA, Johansen B. Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis. Arthritis Res Ther. 2019. 21: 29-41. https://doi.org/10.1186/s13075-018-1794-6
- Fox RE, Hopkins IB, Cabacungan ET, Tildon JT. The role of glutamine and other alternate substrates as energy sources in the fetal rat lung type II cell. Pediatr Res. 1996. 40: 135-141. https://doi.org/10.1203/00006450-199607000-00023
- Franklin CC, Kraft AS. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem. 1997. 272: 16917-16923. https://doi.org/10.1074/jbc.272.27.16917
- Franklin CC, ikanth S Sr, Kraft AS. Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis. Proc Natl Acad Sci USA. 1998. 95: 3014-3019. https://doi.org/10.1073/pnas.95.6.3014
- Griffiths RD. Nutrition support in critically ill septic patients. Curr Opin Clin Nutr Metab Care. 2003. 6: 203-210. https://doi.org/10.1097/01.mco.0000058591.27240.4e
- Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition. 1997. 13: 295-302. https://doi.org/10.1016/S0899-9007(97)00017-8
- Hammer M, Mages J, Dietrich HDietrich H et al. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med. 2006. 203: 15-20. https://doi.org/10.1084/jem.20051753
- Hirabayashi T, Shimizu T. Localization and regulation of cytosolic phospholipase A2. Biochim Biophys Acta. 2000. 1488: 124-138. https://doi.org/10.1016/S1388-1981(00)00115-3
- Hoeck WG, Ramesha CS, Chang DJ, Fan N, Heller RA. Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci USA. 1993. 90: 4475-4479. https://doi.org/10.1073/pnas.90.10.4475
- Im YN, Jeong SY, Youm JY, Lee HK, Im SY. L-glutamine attenuates DSS-induced Colitis via induction of MAPK phosphatase-1. Nutrients. 2018. 10: 288-297. https://doi.org/10.3390/nu10030288
- Jia Z, Babu PV, Si HSi H et al. Genistein inhibits TNF-α-induced endothelial inflammation through the protein kinase pathway A and improves vascular inflammation in C57BL/6 mice. Int J Cardiol. 2013. 168: 2637-2645. https://doi.org/10.1016/j.ijcard.2013.03.035
- Jeong SY, Im SY. Estrogen induces CK2a activation via generation of reactive oxygen species. Biomed Sci Letters. 2019. 25: 23-31. https://doi.org/10.15616/bsl.2019.25.1.23
- Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016. 12: 49-62. https://doi.org/10.1038/nrrheum.2015.169
- Keyse SM, Emslie EA. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase. Nature. 1992. 359: 644-647. https://doi.org/10.1038/359644a0
- Kim JM, Im YN, Chung YJ, et al. Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation. Allergy. 2021. Oct 3. doi: 10.1111/all.15121. Online ahead of print.
- Kim YS, Kim GY, Kim JHKim JH et al. Glutamine inhibits lipopolysaccharide-induced cytoplasmic phospholipase A2 activation and protects against endotoxin shock in mouse. Shock. 2006. 25: 290-294. https://doi.org/10.1097/01.shk.0000194041.18699.6f
- Ko HM, Kang NI, Kim YSKim YS et al. Glutamine preferentially inhibits T-helper type 2 cell-mediated airway inflammation and late airway hyperresponsiveness through the inhibition of cytosolic phospholipase A2 activity in a murine asthma model. Clin Exp Allergy. 2008. 38: 357-364. https://doi.org/10.1111/j.1365-2222.2007.02900.x
- Ko HM, Oh SH, Bang HSBang HS et al. Glutamine protects mice from lethal endotoxic shock via a rapid induction of MAPK phosphatase-1. J Immunol. 2009. 182: 7957-7962. https://doi.org/10.4049/jimmunol.0900043
- Lee CH, Kim HK, Kim JMKim JM et al. Glutamine suppresses airway neutrophilia by blocking cytosolic phospholipase A(2) via an induction of MAPK phosphatase-1. J Immunol. 2012. 189: 5139-5146. https://doi.org/10.4049/jimmunol.1201599
- Lee IT, Lin CC, Cheng SE, Hsiao LD, Hsiao YC, Yang CM. TNF-α induces cytosolic phospholipase A2 expression in human lung epithelial cells via JNK1/2- and p38 MAPK-dependent AP-1 activation. PLoS One. 2013. 8: e72783-72793. https://doi.org/10.1371/journal.pone.0072783
- Leslie CC. Cytosolic phospholipase A2: physiological function and role in disease. J Lipid Res. 2015. 56: 1386-1402. https://doi.org/10.1194/jlr.R057588
- Li J, Gorospe M, Hutter D, Barnes J, Keyse SM, Liu Y. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. Mol Cell Biol. 2001. 21: 8213-8224. https://doi.org/10.1128/MCB.21.23.8213-8224.2001
- Lin CC, Lin WN, Cho RL, Wang CY, Hsiao LD, Yang CM. TNF-α-induced cPLA2 expression via NADPH oxidase/reactive oxygen species-dependent NF-κB cascade on human pulmonary alveolar epithelial cells. Front Pharmacol. 2016. 7: 447-462.
- Lin YW, Yang JL. Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling. J Biol Chem. 2006. 281: 915-926. https://doi.org/10.1074/jbc.M508720200
- Marusic S, Thakker P, Pelker JWPelker JW et al. Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses. J Neuroimmunol. 2008. 204: 29-37. https://doi.org/10.1016/j.jneuroim.2008.08.012
- Misra-Press A, Rim CS, Yao H, Roberson MS, Stork PJ. A novel mitogen-activated protein kinase phosphatase: structure, expression, and regulation. J Biol Chem. 1995. 270: 14587-14596. https://doi.org/10.1074/jbc.270.24.14587
- Monaco C, Nanchahal J, Taylor P, Feldmann M. Anti-TNF therapy: past, present and future. Int Immunol. 2015. 27: 55-62. https://doi.org/10.1093/intimm/dxu102
- Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002. 30: 2022-2029. https://doi.org/10.1097/00003246-200209000-00011
- Omland SH, Habicht A, Damsbo P, Wilms J, Johansen B, Gniadecki RJ. A randomized, double-blind, placebo-controlled, dose-escalation first-in-man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX001, in patients with mild to moderate plaque psoriasis. Eur Acad Dermatol Venereol. 2017. 7: 1161-1167.
- Rosengarten M, Hadad N, Solomonov Y, Lamprecht S, Levy R. Cytosolic phospholipase A2 has a crucial role in the pathogenesis of DSS-induced colitis in mice. Eur J Immunol. 2016. 46: 400-408. https://doi.org/10.1002/eji.201545848
- Sapirstein A, Bonventre JV. Specific physiological roles of cytosolic phospholipase A2 as defined by gene knockouts. Biochim Biophys Acta. 2000. 1488: 139-148. https://doi.org/10.1016/S1388-1981(00)00116-5
- Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumour necrosis factor-α inhibitor therapy. Drugs. 2009. 69: 1403-1415. https://doi.org/10.2165/00003495-200969110-00002
- Su B, Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol. 1996. 8: 402-411. https://doi.org/10.1016/S0952-7915(96)80131-2
- Sun H, Charles CH, Lau LF, Tonks NK. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993. 75: 487-493. https://doi.org/10.1016/0092-8674(93)90383-2
- Taylor P, Williams R, Feldmann M. Tumour necrosis factor as a therapeutic target for immune-mediated inflammatory diseases. Curr Opin Biotechnol. 2004. 15: 557-563. https://doi.org/10.1016/j.copbio.2004.09.005
- Wang J, Yin DP, Liu YX, Baer R, Yin Y. Dual specificity phosphatase 1/CL100 is a direct transcriptional target of E2F-1 in the apoptotic response to oxidative stress. Cancer Res. 2007. 67: 6737-6744. https://doi.org/10.1158/0008-5472.CAN-06-4402
- Wang Z, Xu J, Zhou JY, Liu Y, Wu GS. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. Cancer Res. 2006. 66: 8870-8877. https://doi.org/10.1158/0008-5472.CAN-06-1280
- Wischmeyer PE, Lynch J, Liedel JLiedel J et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001. 29: 2075-2080. https://doi.org/10.1097/00003246-200111000-00006
- Yang D, Ji HF, Zhang XMZhang XM et al. Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis. Mediators Inflamm. 2014. 2014: 890139-890146.
- Zhao Q, Wang X, Nelin LDNelin LD et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med. 2006. 203: 131-140. https://doi.org/10.1084/jem.20051794